이연제약
102460KOSPI50.0 / 100
Reference Date: 2026-10-23
Company InformationBased on 2025 Annual Report
Business Overview
Il Yeon Pharm is a specialized pharmaceutical company established in 1964, focusing on the manufacturing and sales of prescription drugs, original pharmaceuticals (e.g., CT contrast agent 'Optirey'), and bulk drugs. Its Chungju facility, certified for biopharmaceutical production and CMO services, supports new drug pipeline development through a production-platform-based R&D model. However, as of 2024, the company reported sales of 145.9 billion won, an operating loss of 30.3 billion won, and a net loss of 29.6 billion won, indicating the need for improved profitability.
Number of Employees
457people
Average Salary
76.4M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Well below industry avg
Half of industry avg (excellent)
Avg ▼1.7% (2-year basis)
Avg ▼19193.7% (2-year basis)
Avg ROE -3.2% (declining, 3yr)
Detailed News Sentiment
Detailed Momentum
Near 52w low (0%, downtrend)
1m -2.68% (slight drop)
Volume increasing
Detailed Disclosure
- Neutral주식등의대량보유상황보고서(약식)2026-10-20
- Neutral전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)2026-10-16
- Positive유상증자또는주식관련사채등의발행결과(자율공시)2026-10-16
- Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-10-13
- Neutral주요사항보고서(전환사채권발행결정)2026-10-08
